Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1227.00
-18.50 (-1.49%)
< Home < Back

Dr. Reddy's Lab gets EIR for API Srikakulam Plant in Andhra Pradesh

Date: 01-06-2020

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for API Srikakulam Plant (SEZ), Andhra Pradesh, indicating that the inspection is closed under 21 CFR 20.64(d)(3).

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.